122086 -

: Mandatory consultation before changing a patient's medication brand, especially for time-critical drugs.

: Patients often discover medication changes only upon receiving their "plastic boxes" of pills, rather than through prior consultation. 122086

Evidence under reference 122086 illustrates the severe consequences when medication regimes—particularly for long-term metabolic or neurological conditions—are disrupted. A key issue identified is the between different brands of the same drug. 122086

: The evidence underscores the need for better integration between primary and secondary care to ensure that pharmacists can perform their safety-critical roles effectively. Summary of Recommendations The write-up of this evidence suggests a need for: 122086

The evidence reveals a "cloudy picture" of communication between hospitals, consultants, and GPs: